Generics 158

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ceftazidime manufacturers

158 products found

Filters

158 products found

ceftazidime

Powder for solution for injection 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, Greece
Unavailable markets
Kosovo
Manufacturer #298

Manufacturer usually replies in 3 days

ceftazidime

Vials, injection 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Bolivia , Chile , Colombia , Costa Rica , Dominican Republic , El Salvador , Guatemala , Honduras , Nicaragua , Panama , Paraguay , Peru , Ukraine , Uruguay , Venezuela
Comments
DCP 03/2023 ongoing, RMS NL
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

ceftazidime

Injection 1 g - 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17360
It is a privately held company that was founded in the 1940s in Italy. Several patents under the company's name have been obtained in Europe and the United States. High standards are ensured by the use of advanced computerized systems for the production of all pharmaceutical dosage forms, including tablets, capsules, syrups, sterile ampoules, and powder for injectable vials.

Manufacturer usually replies in 8 days

ceftazidime

Powder for solution for injection 1 g, 2 g - 10 ml, 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iran , Vietnam
Available for
Distribution only
Manufacturer #12969
It is a pharmaceutical company run by a family. It is a forward-thinking entrepreneurial and manufacturing company that is expanding in tandem with the growth of drug alternatives (generics) in Europe and around the world. It sells generic prescription drugs under its brand name (branded generics) in both common and specialty forms, as well as branded OTC medicines, medical devices, and food supplements across the country.

Manufacturer usually replies in 7 days

ceftazidime

Powder and solvent for solution for infusion 1 g, 2 g - 20 ml , 50 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Technology transfer
Comments
Reference product: Fortum® Supply temporally restricted, looking for CMO. Technology Transfer available.
Manufacturer #10142
They have more than 40 generic drug products available for license to our global partners. The EU-CTD format is used for all product dossiers. All generic drug products are manufactured in the European Union (EU) and distributed globally to brand partners. Concentrate on delivering high-quality products on time and at a reasonable price.

Manufacturer usually replies in 9 days

ceftazidime

Powder and solvent for solution for injection 500 mg, 1 g - 10 ml, 20ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Technology transfer
Comments
Reference product: Fortum® Supply temporally restricted, looking for CMO. Technology Transfer available.
Manufacturer #10142
They have more than 40 generic drug products available for license to our global partners. The EU-CTD format is used for all product dossiers. All generic drug products are manufactured in the European Union (EU) and distributed globally to brand partners. Concentrate on delivering high-quality products on time and at a reasonable price.

Manufacturer usually replies in 9 days

ceftazidime

Solution for infusion 1 g, 2 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , United Arab Emirates
Available for
Licensing with supply
Manufacturer #9267

A highly trusted and reliable name for WHO-approved pharmaceutical products that deals in exports as well. With modern facilities and excellent product conditions, they are known to provide superlative services aimed at keeping the community disease-free and healthy at the same time.

Manufacturer usually replies in 8 days

ceftazidime

Vials, injection 1g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11676
It is the fastest-growing pharmaceutical manufacturer operating in South-East Europe. The company is focused on making available contemporary therapeutical solutions in the local, regional and European markets under GMP. The company has expertise in fast market penetration is proven by the results achieved for their partners.

Manufacturer usually replies in 6 days

ceftazidime

Solution for injection 250mg 500mg 1mg 2mg 6 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA
Unavailable markets
United States , Vietnam
Manufacturer #5601
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products for 50+ years. Key production lines are Rx and nutraceuticals. The company's production lines are cGMP-compliant. Main therapeutic areas include anti-infectives. Main dosage forms include oral and injectables The company possesses 20+ production facilities.

Manufacturer usually replies in 6 days

ceftazidime

Solution for infusion 2g - 50ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

ceftazidime

Solution for injection 1g - 20ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #651

Manufacturer usually replies in 6 days

ceftazidime

Solution for injection 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15070

A pharmaceutical manufacturer based in the EU that is selling its products in EU, CIS, and Asia. Key production lines are Rx, OTC, medical devices, and nutraceuticals. The company's production lines are EU GMP-compliant.

Manufacturer usually replies in 8 days

ceftazidime + avibactam

Powder for solution for infusion 2 g + 500 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Dossier availability date: 2025
Manufacturer #21467

Manufacturer usually replies in 9 days

ceftazidime + avibactam

Powder for solution for injection 2 g + 0.5 g

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Very early stage of development
Manufacturer #2346

Manufacturer usually replies in 7 days

ceftazidime

Vials, injection 250 mg, 500 mg, 1 g, 2 g

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

ceftazidime

Powder for solution for injection/infusion 2g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16200
It is a medium-sized international pharmaceutical firm with headquarters, development, and manufacturing in Europe with a corporate history spanning more than 65 years. The mission statement is entirely focused on providing high-quality medicines to clients promptly. Our continued success is built on qualified employees, cutting-edge production facilities and processes, as well as an appreciative and performance-enhancing corporate culture.

Manufacturer usually replies in 13 days

ceftazidime

Powder for solution for injection/infusion 250 mg, 500 mg, 1 g, 2 g, 3 g, 6 g

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #354

ceftazidime

Vials, injection 500mg, 1g, 2g, 6g

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
Canada, FDA
Unavailable markets
United States
Manufacturer #12195

Manufacturer usually replies in 9 days

ceftazidime

Powder for solution for injection/infusion 1 g, 2 g

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Dossier availability depending on country legislation
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

ceftazidime

Powder and solvent for solution for injection 1000 mg, 500 mg, 250 mg - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, Afghanistan, India
Registered in
India , Afghanistan , Iraq
Available for
Licensing with supply, Distribution only, Technology transfer
Manufacturer #22627

Manufacturer usually replies in 4 days

Want to view all 158 products? Create your free account today!

Ceftazidime Manufacturers

Ceftazidime infusion is used to treat bacterial infections such as pneumonia and other respiratory tract infections, meningitis, an infectious disease of the membrane surface that includes the brain and spinal cord, and other brain and spine infections, as well as infections of the abdomen skin, plasma, female genitourinary area, and urinary tract. Ceftazidime injection belongs to the cephalosporin antibiotics family of drugs. Ceftazidime is also useful for a variety of things. It's unclear whether this medication may harm an unborn child. If you are pregnant or plan to become pregnant, tell your doctor. It's unclear whether Ceftazidime sodium medication goes into breastfeeding.

How Does Ceftazidime Work?

Ceftazidime works as a selective antagonist of bacterial para-aminobenzoic acid, which is required for the growth of bacteria (according to the Woods-Fildes theory). The blocked process is required to synthesize folic acid in these organisms. Sulfonamides are found in large amounts in all tissues. Pericardial effusion, peritoneal, joint, and ophthalmic fluids are high. CSF levels are high in meningeal infections, even though these medications are no longer used to treat meningitis. Pust inhibits their antimicrobial activity.

Wholesale Price of Ceftazidime

Based on the supplier you visit, Ceftazidime injectable powder for administration 1 g costs roughly $93 for a batch of 25 powder for infusion. Ceftazidime is available for sale from various Ceftazidime vendors at a range of costs. Prices are applicable just for cash consumers and do not apply to insurance policies. Ceftazidime suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers. Its price may vary depending on the country of origin, wholesale costs incurred by manufacturing companies, supplier pricing, and similar factors. Pharmaceutical corporations generally support patient support programs.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Ceftazidime offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Ceftazidime suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Ceftazidime. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, countries where Ceftazidime is already registered in. Manufacturers also have special and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Ceftazidime suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Ceftazidime manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.